The Discounted Cash Flow (DCF) valuation of Blueprint Medicines Corp (BPMC) is (33.41) USD. With the latest stock price at 129.46 USD, the upside of Blueprint Medicines Corp based on DCF is -125.8%.
Based on the latest price of 129.46 USD and our DCF valuation, Blueprint Medicines Corp (BPMC) is a sell. selling BPMC stocks now will result in a potential gain of 125.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.9% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (82.13) - (22.73) | (33.41) |
| Upside | -163.4% - -117.6% | -125.8% |